UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression

Immunity (Cambridge, Mass.), 2021-08, Vol.54 (8), p.1772-1787.e9

2021

Volltextzugriff (PDF)

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy

Journal of nanobiotechnology, 2007-04, Vol.5 (1), p.3-3, Article 3

2007

Volltextzugriff (PDF)

Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6249

2024

Volltextzugriff (PDF)

Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses

Cancer Immunology, Immunotherapy, 2021-01, Vol.70 (1), p.107-121

2021

Volltextzugriff (PDF)

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors

Cancer biology & therapy, 2011-03, Vol.11 (5), p.464-473

2011

Volltextzugriff (PDF)

Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.23 (1), p.61-77

2011

Volltextzugriff (PDF)

Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysis

Hematology (Luxembourg), 2023-12, Vol.28 (1), p.2212536-2212536

2023

Volltextzugriff (PDF)

An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer

Molecular cancer therapeutics, 2008-09, Vol.7 (9), p.2725-2735

2008

Volltextzugriff (PDF)

A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation

Laboratory investigation, 2011-09, Vol.91 (9), p.1383-1395

2011

Volltextzugriff (PDF)

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

Cancer biology & therapy, 2009-04, Vol.8 (7), p.618-626

2009

Volltextzugriff (PDF)

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer

BMC cancer, 2017-04, Vol.17 (1), p.249-10, Article 249

2017

Volltextzugriff (PDF)

Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models

Cancer biology & therapy, 2011-10, Vol.12 (7), p.598-609

2011

Volltextzugriff (PDF)

A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

Oncotarget, 2012-06, Vol.3 (6), p.640-650

2012

Volltextzugriff (PDF)

Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma

Translational oncology, 2014-04, Vol.7 (2), p.309-321

2014

Volltextzugriff (PDF)

Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target

Translational oncology, 2015-08, Vol.8 (4), p.295-307

2015

Volltextzugriff (PDF)

In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities

Molecular cancer therapeutics, 2008-12, Vol.7 (12), p.3878-3888

2008

Volltextzugriff (PDF)

Ectopic Overexpression of Sonic Hedgehog (Shh) Induces Stromal Expansion and Metaplasia in the Adult Murine Pancreas

Neoplasia (New York, N.Y.), 2011-10, Vol.13 (10), p.923-IN18

2011

Volltextzugriff (PDF)

Animal models for modeling pancreatic cancer and novel drug discovery

Expert opinion on drug discovery, 2019-02, Vol.14 (2), p.127-142

2019

Volltextzugriff (PDF)

Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases

International journal of endocrinology, 2020, Vol.2020 (2020), p.1-9

2020

Volltextzugriff (PDF)

Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2009-07, Vol.1 (4), p.415-425

2009

Volltextzugriff (PDF)

Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts

Oncology research and treatment, 2018-01, Vol.41 (10), p.596-602

2018

Volltextzugriff (PDF)

Systemic Delivery of Curcumin: 21st Century Solutions for an Ancient Conundrum

Current drug discovery technologies, 2009-09, Vol.6 (3), p.192-199

2009

Volltextzugriff (PDF)

Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma

Oncology research and treatment, 2018-01, Vol.41 (10), p.590-594

2018

Volltextzugriff (PDF)

pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery

International journal of pharmaceutics, 2005-01, Vol.288 (1), p.157-168

2005

Volltextzugriff (PDF)

Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice: A mouse model of familial pancreatic cancer

Cancer biology & therapy, 2011-06, Vol.11 (11), p.959-968

2011

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(64)
Buchkapitel
(3)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(39)
Humans
(25)
Oncology
(22)
Animals
(18)
Cell Line, Tumor
(14)
Mice
(14)
Pancreatic Cancer
(14)
Pancreatic Neoplasms - Pathology
(13)
Pancreatic Neoplasms - Drug Therapy
(12)
Pancreatic Neoplasms - Genetics
(9)
Male
(8)
Xenograft Model Antitumor Assays
(8)
Antineoplastic Agents - Pharmacology
(7)
Cancer
(7)
Pharmacology & Pharmacy
(7)
Tumors
(7)
Cell Proliferation - Drug Effects
(6)
Antineoplastic Agents - Pharmacokinetics
(5)
Biological And Medical Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy

Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer

Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors

Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease

Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysis

An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer

A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer

Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models

A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma

Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread—Identification of a Promising Novel therapeutic target

In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities

Ectopic Overexpression of Sonic Hedgehog (Shh) Induces Stromal Expansion and Metaplasia in the Adult Murine Pancreas

Animal models for modeling pancreatic cancer and novel drug discovery

Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases

Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy

Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts

Systemic Delivery of Curcumin: 21st Century Solutions for an Ancient Conundrum

Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma

pDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery

Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice: A mouse model of familial pancreatic cancer

Suchergebnisse filtern